Skip to content
Company Analysis

OrthoPediatrics Corp. KIDS

A comprehensive view of key metrics, scores, and financial health for OrthoPediatrics Corp.

Overview of OrthoPediatrics Corp.

KIDS NGM
Healthcare Medical Devices Framework: Medical Devices & Diagnostics Small Cap
OrthoPediatrics Corp. (KIDS), is a Small Cap company, in the Medical Devices industry, last closed at $17.82, about 35.7% overvalued vs fair value, -15.8% 1Y return, ranked 881/1122 in sector.
Metrics Rev Growth 15.5% ROE -11.3% Gross Margin 73.1%
USD 17.82
-0.06%
(Delayed)
• Vol 90d: 44.5%
52-Week Range
Market Cap
$458.00M
Enterprise Value
$486.80M
Overall Score
View breakdown
Overall
Growth
Weak
Profitability
Good
Health
Weak
Efficiency
Weak
Valuation
Weak
Growth
Weak
Profitability
Good
Health
Weak
Efficiency
Weak
Valuation
Weak
Completeness: 82%
Confidence: 79%
Updated: Mar 8
Top Beats

Quick Facts

Website https://www.orthopediatrics.co...
HQ Warsaw, IN
Employees 562
Fiscal year Dec 31

Next Events

No upcoming events available.

Fair Value Snapshot

Bear Base Bull
$10
$11
$13
Current: $17.82 -36% vs base

Engine Room Money Flow™

Small Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$236.3M
15.4%%
Gross Profit
$172.7M
16.2%%
Operating Income (GAAP)
$-29.0M
1.8%%
EBITDA
$-29.0M
-177.7%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

Gross Margin
73.1%
Excellent

Gross Profit / Revenue — primary moat signal for MedTech. ≥65% indicates IP-protected consumables with strong pricing power.

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
2
Active Leaks
0/2
Improving
0
High Impact
2
Critical
Locked Leak
Upgrade to view details
Premium
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating OrthoPediatrics Corp.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
65
/100
Moderate
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Strong
86
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Healthcare: MedTech (Devices & Supplies) vs Industry Peers 83% Coverage
Trade-Off Triangle Visualization A ternary plot showing KIDS's balance between Growth (34.6%), Profitability (36.2%), and Safety (29.1%). Growth 35% Safety 29% Profitability 36%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

56th percentile vs peers
57
Key Signals
Rev Growth YoY 15.4% 68p Revenue CAGR 3Y 24.6% 79p Asset Growth YoY 7.5% 70p EPS Growth YoY -77.2% 12p
Strengths
  • Gross Profit Margin in top 20% of peers (73.0%, 82th percentile)
Risks
  • EPS Growth YoY in bottom 20% of peers (-77.2%)

Profitability

59th percentile vs peers
60
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

47th percentile vs peers
48
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for OrthoPediatrics Corp..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$11.45
- - -
-35.7% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000